Cargando…
Eculizumab in recalcitrant antiphospholipid antibody syndrome
Autores principales: | Zapantis, Ekaterini, Furie, Richard, Horowitz, Diane |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4179587/ http://dx.doi.org/10.1186/ar4666 |
Ejemplares similares
-
Eculizumab for refractory thrombosis in antiphospholipid syndrome
por: Hussain, Habiba, et al.
Publicado: (2022) -
Cerebrovascular insult and antiphospholipid antibodies in young adults
por: Cucnik, S, et al.
Publicado: (2002) -
Antibodies to beta(2)-glycoprotein I, prothrombin and antithrombin III as markers of the antiphospholipid syndrome severity
por: Zabek, J, et al.
Publicado: (2001) -
Prothrombin fragment F1+2 in patients with antiphospholipid antibodies
por: Ambrozic, A, et al.
Publicado: (2004) -
Efficacy and safety of the use of omalizumab in a patient with difficult-to-control severe asthma and antiphospholipid antibody syndrome
por: Villela, Rosangela, et al.
Publicado: (2015)